Quest Ebitda from 2010 to 2024

Stocks . Canada . 
Stock . Quest PharmaTech
QPT Stock  CAD 0.03  0.01  25.00%   
Quest PharmaTech EBITDA yearly trend continues to be fairly stable with very little volatility. EBITDA is likely to outpace its year average in 2024. During the period from 2010 to 2024, Quest PharmaTech EBITDA regression line of quarterly data had mean square error of 3385.8 T and geometric mean of  12,419,064. View All Fundamentals
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
-6.6 M
Current Value
-6.2 M
Quarterly Volatility
56.3 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Quest PharmaTech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Quest PharmaTech's main balance sheet or income statement drivers, such as Interest Expense of 21.7 K, Selling General Administrative of 1.4 M or Total Revenue of 0.0, as well as many indicators such as . Quest financial statements analysis is a perfect complement when working with Quest PharmaTech Valuation or Volatility modules.
  
This module can also supplement various Quest PharmaTech Technical models . Check out the analysis of Quest PharmaTech Correlation against competitors.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Quest Stock Analysis

When running Quest PharmaTech's price analysis, check to measure Quest PharmaTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest PharmaTech is operating at the current time. Most of Quest PharmaTech's value examination focuses on studying past and present price action to predict the probability of Quest PharmaTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest PharmaTech's price. Additionally, you may evaluate how the addition of Quest PharmaTech to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY